Lenalidomide for the hampton VAMC for patient care.
Active Awarded Last action
- Contract number
- 36C24626N0406
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,554,893
Award facts
- Contract value 100% obligated
- $1,554,892.65 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order valued at $1.55M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide to support patient care at the Hampton Veterans Affairs Medical Center. The contract, issued on January 15, 2026, utilizes a firm fixed-price delivery order structure under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of January 14, 2027. No set-aside designation was applied to this procurement, allowing competition on an unrestricted, fully open basis. Exelan Pharmaceuticals, a Boca Raton, Florida-based pharmaceutical manufacturing and distribution company, will perform the work at its primary facility and designated delivery locations.
Lenalidomide is a critical immunomodulatory agent used in the treatment of oncologic and hematologic malignancies within the VA healthcare system. Exelan has established itself as a primary supplier of Lenalidomide to multiple Veterans Integrated Service Networks through an extensive portfolio of delivery orders and framework agreements, including a Blanket Purchase Agreement with Veterans Integrated Service Network 22 valued at $21.17M. The company operates as a prime contractor with no major subcontractors and has demonstrated substantial capacity to fulfill large-scale pharmaceutical supply requirements across multiple federal healthcare agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service.
Quick answers
Who was awarded contract 36C24626N0406?
36C24626N0406 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C24626N0406 worth?
The government has obligated $1,554,893 on 36C24626N0406.
Is contract 36C24626N0406 an order under another contract?
Yes. 36C24626N0406 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0406 competed?
The extent of competition for 36C24626N0406 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award